24 Jun 2025
// PR NEWSWIRE
29 Jan 2025
// PR NEWSWIRE
01 Jan 2025
// FDA
Latest Content by PharmaCompass
Reset all filters
01 2ACETAZOLAMIDE
02 1ALCOHOL
03 6AMITRIPTYLINE HYDROCHLORIDE
04 2APIXABAN
05 3ASENAPINE MALEATE
06 2BENDAMUSTINE HYDROCHLORIDE
07 1BRETYLIUM TOSYLATE
08 1CABAZITAXEL
09 2CARFILZOMIB
10 3DABIGATRAN ETEXILATE MESYLATE
11 4DULOXETINE HYDROCHLORIDE
12 2ENTECAVIR
13 2EPLERENONE
14 2ESTRADIOL; NORETHINDRONE ACETATE
15 7EVEROLIMUS
16 1EXEMESTANE
17 4FLUPHENAZINE HYDROCHLORIDE
18 1LAMIVUDINE
19 1METHADONE HYDROCHLORIDE
20 2METHSCOPOLAMINE BROMIDE
21 1METHYLERGONOVINE MALEATE
22 1MONTELUKAST SODIUM
23 1NOREPINEPHRINE BITARTRATE
24 3OMEPRAZOLE
25 3OXCARBAZEPINE
26 1PENICILLAMINE
27 2PIROXICAM
28 1POLYETHYLENE GLYCOL 3350
29 4POMALIDOMIDE
30 2POTASSIUM CHLORIDE
31 3RIVAROXABAN
32 3RIVASTIGMINE
33 2SOLIFENACIN SUCCINATE
34 1SUCCINYLCHOLINE CHLORIDE
35 1TERBINAFINE HYDROCHLORIDE
36 2TERIFLUNOMIDE
37 2TETRACYCLINE HYDROCHLORIDE
38 1TOFACITINIB
39 2TRIAZOLAM
40 3TRIMIPRAMINE MALEATE
41 1ZOLEDRONIC ACID
42 2ZOLPIDEM TARTRATE
Reset all filters
01 7CAPSULE, DELAYED REL PELLETS;ORAL
02 15CAPSULE;ORAL
03 3FILM, EXTENDED RELEASE;TRANSDERMAL
04 1FOR SOLUTION;ORAL
05 5INJECTABLE;INJECTION
06 1INJECTABLE;INTRAVENOUS
07 4POWDER;INTRAVENOUS
08 1SOLUTION;INTRA-ARTERIAL
09 1SOLUTION;INTRAVENOUS
10 4TABLET, EXTENDED RELEASE;ORAL
11 46TABLET;ORAL
12 3TABLET;SUBLINGUAL
Reset all filters
01 10.125MG
02 20.25MG
03 10.2MG/ML
04 20.5MG
05 10.5MG;0.1MG
06 10.75MG
07 1100MG
08 1100MG/VIAL
09 110MEQ
10 710MG
11 110MG/ML
12 110MG/VIAL
13 112.5MG
14 1125MG
15 113.3MG/24HR
16 114MG
17 3150MG
18 115MG
19 117GM/SCOOPFUL
20 31MG
21 11MG;0.5MG
22 42.5MG
23 120MEQ
24 320MG
25 120MG/ML
26 3250MG
27 325MG
28 125MG/VIAL
29 12MG
30 1300MG
31 13MG
32 14.6MG/24HR
33 140MG
34 14MG
35 1500MG
36 250MG
37 150MG/ML
38 65MG
39 16.25MG
40 1600MG
41 160MG/1.5ML (40MG/ML)
42 160MG/VIAL
43 17.5MG
44 175MG
45 17MG
46 19.5MG/24HR
47 199% (5ML)
48 1EQ 100MG BASE
49 2EQ 10MG BASE
50 1EQ 110MG BASE
51 1EQ 150MG BASE
52 1EQ 1MG BASE/ML
53 1EQ 2.5MG BASE
54 1EQ 20MG BASE
55 1EQ 250MG BASE
56 1EQ 25MG BASE
57 1EQ 30MG BASE
58 1EQ 40MG BASE
59 1EQ 4MG BASE/5ML
60 1EQ 50MG BASE
61 1EQ 5MG BASE
62 1EQ 60MG BASE
63 1EQ 75MG BASE
Reset all filters
01 31DISCN
02 58RX
03 2Blank
RLD : No
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : ACETAZOLAMIDE
Dosage Strength : 125MG
Approval Date : 2020-04-30
Application Number : 207503
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : ACETAZOLAMIDE
Dosage Strength : 250MG
Approval Date : 2020-04-30
Application Number : 207503
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD :
TE Code :
Dosage Form : SOLUTION; INTRA-ARTERIAL
Proprietary Name : DEHYDRATED ALCOHOL
Dosage Strength : 99% (5ML)
Approval Date :
Application Number : 219444
RX/OTC/DISCN :
RLD :
TE Code :
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : AMITRIPTYLINE HYDROCHLOR...
Dosage Strength : 10MG
Approval Date : 2022-06-06
Application Number : 216243
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : AMITRIPTYLINE HYDROCHLOR...
Dosage Strength : 25MG
Approval Date : 2022-06-06
Application Number : 216243
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : AMITRIPTYLINE HYDROCHLOR...
Dosage Strength : 50MG
Approval Date : 2022-06-06
Application Number : 216243
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : AMITRIPTYLINE HYDROCHLOR...
Dosage Strength : 75MG
Approval Date : 2022-06-06
Application Number : 216243
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : AMITRIPTYLINE HYDROCHLOR...
Dosage Strength : 100MG
Approval Date : 2022-06-06
Application Number : 216243
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : AMITRIPTYLINE HYDROCHLOR...
Dosage Strength : 150MG
Approval Date : 2022-06-06
Application Number : 216243
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : APIXABAN
Dosage Strength : 2.5MG
Approval Date : 2021-07-26
Application Number : 209845
RX/OTC/DISCN : DISCN
RLD : No
TE Code :